HAINS Mycobacterium tuberculosis Second-Line Drug Test: Booking, Price, and Results
About HAINS Mycobacterium tuberculosis Second-Line Drug Test: Booking, Price, and Results
| Field | Value |
|---|---|
| Also Known As | MTBDRsl, GenoType MTBDRsl, Second-line LPA, Hain LPA second-line, SL-LPA, second-line drug susceptibility testing |
| Sample Type | Sputum, bronchoalveolar lavage (BAL), gastric aspirate, pus, tissue biopsy, body fluids, culture isolate, or other clinically indicated respiratory specimens |
| Fasting Required | No |
| Report Time | 15 Days |
| Recommended For | Adults and children with confirmed rifampicin-resistant TB or multidrug-resistant TB requiring assessment for second-line drug resistance |
| Price | Starting at ₹5,400 |
What is a HAINS Mycobacterium tuberculosis Second-Line Drug Test?
The HAINS Mycobacterium tuberculosis second-line drug test is a specialised molecular assay that detects resistance to second-line anti-tuberculosis drugs in TB-causing bacteria. It is also known as the MTBDRsl or GenoType MTBDRsl assay. Doctors prescribe this test when a patient has already been diagnosed with rifampicin-resistant TB (RR-TB) or multidrug-resistant TB (MDR-TB) and needs further assessment before starting second-line treatment. The test is performed on sputum, bronchoalveolar lavage, gastric aspirate, pus, tissue biopsy, body fluids, a culture isolate, or other clinically indicated specimens using a next-generation sequencing (NGS) method.
What Does a HAINS Mycobacterium tuberculosis Second-Line Drug Test Measure?
This test analyses specific gene mutations in the TB bacteria to determine which second-line drugs the strain is resistant to or susceptible to. The key parameters are listed below.
| Parameter | What it Detects |
|---|---|
| gyrA and gyrB gene mutations | Resistance to fluoroquinolones (ofloxacin, moxifloxacin, levofloxacin, gatifloxacin) |
| rrs gene mutations | Resistance to second-line injectable drugs (kanamycin, amikacin, capreomycin) |
| eis promoter region mutations | Low-level kanamycin resistance (version 2.0 of the assay) |
| Mycobacterium tuberculosis complex identification | Confirms the presence of TB-causing bacteria in the sample |
Why is a HAINS Mycobacterium tuberculosis Second-Line Drug Test Done?
This test is ordered when standard TB treatment has not worked, and doctors need to understand which second-line drugs the bacteria will respond to. Below are the common reasons a doctor may request it.
Common Symptoms That May Require This Test
Patients who are already under TB treatment and show the following symptoms may be assessed for drug resistance:
- Persistent cough lasting more than two weeks despite ongoing treatment
- Fever, chills, and night sweats that do not resolve
- Unexplained fatigue and muscle weakness
- Continued weight loss during treatment
- Shortness of breath or chest discomfort
Conditions This Test Can Help Detect
The HAINS Mycobacterium tuberculosis second-line drug test helps identify several serious forms of drug-resistant TB:
- Multidrug-resistant TB (MDR-TB): resistance to at least isoniazid and rifampicin, the two most potent first-line TB drugs
- Pre-XDR-TB: MDR-TB with additional resistance to either fluoroquinolones or second-line injectable drugs
- Extensively drug-resistant TB (XDR-TB): resistance to rifampicin plus at least one fluoroquinolone and at least one other Group A drug, such as bedaquiline or linezolid
- Treatment failure cases requiring a change in therapy
HAINS Mycobacterium tuberculosis Second-Line Drug Test for Chronic Disease Monitoring
The World Health Organisation recommends this assay as an initial test to detect resistance to fluoroquinolones and second-line injectable drugs in confirmed RR-TB or MDR-TB patients, instead of waiting for slower culture-based testing. In patients on long-term drug-resistant TB treatment, this second-line drug susceptibility test helps monitor treatment effectiveness and identify emerging resistance. Tracking resistance patterns through such assays can guide clinicians in adjusting regimens to improve outcomes.
How to Prepare and What to Expect
Sample collection for the HAINS Mycobacterium tuberculosis second-line drug test procedure is straightforward, but following the steps below carefully helps ensure a good-quality specimen.
Do You Need to Fast?
No fasting is required for this test. You may eat and drink normally before providing your sample. However, rinsing your mouth with plain water just before collection is recommended, as it helps remove food particles and oral bacteria that could affect the sample.
Practical Tips Before Your Test
The following steps will help ensure your sample is suitable for testing:
- Bring a detailed clinical history, including your symptoms, previous test results, and family history, as this is required for the test
- Rinse your mouth with water (not mouthwash) immediately before producing a sputum sample
- Try to collect sputum first thing in the morning, as early morning samples tend to have a higher bacterial load
- Ensure the container is airtight after collection to avoid contamination
- Inform the collection team about any current medications, including TB drugs, as these can affect results
- Wear comfortable clothing with easy access to your chest area if you are attending a centre
Step-by-Step Procedure
The HAINS Mycobacterium tuberculosis second-line drug test can be performed on several sample types. The collection process differs by sample type, as described below.
Sputum (expectorated or induced):
- Rinse your mouth with plain water just before collection.
- Take two deep breaths, hold each for a few seconds, then exhale slowly to loosen secretions in the lungs.
- Take another deep breath, hold briefly, and cough deeply to bring up material from the lungs (not just saliva).
- Hold the sterile container close to your lips and spit the sputum directly into it; if the amount is insufficient, cough again until enough material is collected (at least 3 ml).
- Close the container tightly, label it, and hand it over to the collection team immediately.
- The sample is refrigerated at 2 to 8°C and transported to the laboratory, where it undergoes DNA extraction, multiplex PCR amplification, and reverse hybridisation analysis.
Bronchoalveolar Lavage (BAL) and Bronchial Wash:
- This procedure is performed by a doctor or trained specialist, usually in a clinical or hospital setting.
- A thin flexible tube (bronchoscope) is passed through the nose or mouth into the airways.
- A small amount of sterile fluid is introduced into the lower airways and then gently suctioned back, collecting cells and secretions.
- The fluid is collected in a sterile container, sealed, and labelled.
- The sample is refrigerated promptly and dispatched to the laboratory for molecular testing.
Gastric Aspirate (primarily used in young children):
- This procedure is carried out by a trained healthcare professional, usually in the early morning before the child has eaten.
- A thin tube is passed through the nose into the stomach to collect fluid that contains swallowed respiratory secretions.
- The aspirate is placed into a sterile container, sealed, and labelled immediately.
- The sample is refrigerated and transported to the laboratory with the clinical history.
Pus, Tissue Biopsy, and Body Fluids:
- These samples are collected by a doctor during a clinical procedure such as a biopsy, aspiration, or surgical drainage.
- The collected material is placed into a sterile container in sufficient volume (minimum 5 ml where possible).
- The container is sealed tightly, labelled, and refrigerated at 2 to 8°C.
- The sample is transported to the laboratory as quickly as possible with a complete clinical history attached.
Culture Isolate:
- If you already have a confirmed TB culture from a previous test, the laboratory can use that isolate directly.
- The culture isolate is transferred into an appropriate sterile container and sent to the Lupin Diagnostics laboratory.
- The laboratory performs DNA extraction and the line probe assay on the isolate.
Factors That Can Affect Accuracy
Several factors can influence the reliability of the HAINS Mycobacterium tuberculosis second-line drug test:
- Poor sample quality (saliva rather than true sputum) reduces sensitivity
- Smear-negative samples may yield suboptimal results compared with smear-positive ones
- Presence of non-tuberculous mycobacteria can cause a negative MTB result even when acid-fast bacilli are visible on smear
- PCR inhibitors present in some samples can produce invalid results
- Improper storage or delays in transportation can degrade the sample
- Contamination during collection can interfere with the molecular analysis
Understanding Your HAINS Mycobacterium tuberculosis Second-Line Drug Test Results
Results are reported qualitatively. Your doctor will review the findings together with your clinical history and previous test results. The reference ranges below give a general guide to what the results mean.
| Parameter | Result | Interpretation |
|---|---|---|
| MTB complex identification | Detected | TB-causing bacteria present in the sample |
| MTB complex identification | Not Detected | TB-causing bacteria not found |
| Fluoroquinolone resistance (gyrA/gyrB) | Susceptible | No resistance mutations identified |
| Fluoroquinolone resistance (gyrA/gyrB) | Resistant | Resistance mutations present |
| Second-line injectable drug resistance (rrs/eis) | Susceptible | No resistance mutations identified |
| Second-line injectable drug resistance (rrs/eis) | Resistant | Resistance mutations present |
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
Results During Special Conditions
Certain conditions can influence how results are interpreted:
- HIV infection is a known risk factor for drug-resistant TB, including XDR-TB. Patients with HIV co-infection may face a higher likelihood of resistance, and doctors often coordinate TB and HIV management together in such cases.
- When non-tuberculous mycobacteria are present in a sample, the MTB complex may show as not detected even if acid-fast bacilli are visible under the microscope. A repeat test or additional culture confirmation may be recommended in such situations.
- Patients with a history of previous TB treatment failure or prolonged hospitalisation carry a higher risk of harbouring MDR or XDR-TB strains, which may affect how results are used to guide treatment decisions.
How to Maintain Healthy Levels
The following general wellness practices support TB management and overall respiratory health:
- Complete the full prescribed course of TB treatment without interruption, even when symptoms improve, to prevent resistance from developing or worsening
- Maintain good ventilation in your living and sleeping spaces and practise cough hygiene (cover your mouth when coughing)
- If TB is diagnosed, speak with your doctor about testing for HIV, as co-infection requires coordinated care planning
Lupin Diagnostics HAINS Mycobacterium tuberculosis Second-Line Drug Test Price and Home Collection
The HAINS Mycobacterium tuberculosis second-line drug test cost at Lupin Diagnostics starts at ₹5,400, and home sample collection is available for sputum samples across serviceable cities.
| City | Approximate Price (₹) |
|---|---|
| Mumbai | 5500 |
| Pune | 5500 |
| Bangalore | 5500 |
| Chennai | 5500 |
Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
- Select the test on the Lupin Diagnostics website.
- Choose your city and preferred time slot.
- Opt for home sample collection by a certified phlebotomist, or visit your nearest Lupin Diagnostics centre.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Home Collection
HAINS Mycobacterium tuberculosis second-line drug test home collection is available for sputum samples across cities where Lupin Diagnostics operates. A trained phlebotomist visits your location, guides you through correct sputum collection, and transports the sealed sample immediately to the laboratory under refrigerated conditions. All samples are processed in NABL-accredited laboratories, and reports are delivered digitally via email or WhatsApp.
Frequently Asked Questions
This test is recommended for patients who have been confirmed with rifampicin-resistant TB or multidrug-resistant TB. The World Health Organisation recommends it as an initial test for second-line drug resistance in both adults and children with these diagnoses. Your doctor will advise you based on your current TB status and treatment history.
The report is delivered within 15 days. Conventional culture-based drug susceptibility testing can take two to six weeks, making molecular assays like this one a faster option for guiding treatment decisions.
The HAINS Mycobacterium tuberculosis second-line drug test checks for resistance to fluoroquinolones (including ofloxacin, moxifloxacin, levofloxacin, and gatifloxacin) and second-line injectable drugs (including kanamycin, amikacin, and capreomycin). These are key drugs used when first-line TB treatment fails.
No, these are different tests. GeneXpert primarily detects TB and checks for rifampicin resistance, which is a first-line drug assessment. The HAINS Mycobacterium tuberculosis second-line drug test goes a step further by detecting mutations associated with resistance to fluoroquinolones and aminoglycosides, drugs that are only used when first-line treatment has failed.
Sputum sample collection for the HAINS Mycobacterium tuberculosis second-line drug test home collection service can be done at your home with assistance from a trained collection professional. However, samples such as BAL, biopsy, or gastric aspirate require collection at a clinical facility. The laboratory analysis itself is always carried out at a specialised accredited laboratory.
If resistance mutations are found, your doctor will review the specific pattern of resistance and plan a modified treatment regimen using drugs that are still effective. This is a critical step in managing drug-resistant TB and ensuring treatment does not fail further.
The GenoType MTBDRsl assay is included as a frontline test for second-line resistance detection in MDR-TB, RR-TB, and isoniazid-resistant TB under India's national TB elimination programme. Early detection of resistance through the HAINS Mycobacterium tuberculosis second-line drug test helps prevent the spread of resistant strains and allows doctors to start the most appropriate treatment without delay.
HAINS Mycobacterium tuberculosis Second-Line Drug Test: Booking, Price, and Results
